EVGN - エボジェン (Evogene Ltd.) エボジェン

 EVGNのチャート


 EVGNの企業情報

symbol EVGN
会社名 Evogene Ltd (エボジェン)
分野(sector) Basic Industries   素材
産業(industry) Agricultural Chemicals  
業種    原材料・素材(Materials)
概要 事業概要 --   エボジェンはイスラエルの植物ゲノム会社。バイオテクノロジ―と高度育種法を駆使し、種子の成長と生産性の向上を促す包括的なソリュ―ションを影響。トウモロコシ、大豆、小麦、米等の主要作物の生産性の向上、および耐乾性と耐病性強化などの形質を付与する育種技術の開発に向けて、農業従事者と戦略的に業務提携を行う。   Evogene is a leading computational biology company focused on revolutionizing product discovery and development in multiple life-science based industries, including human health and agriculture, through the use of its broadly applicable Computational Predictive Biology (CPB) platform. The CPB platform, incorporating a deep understanding of biology leveraged through the power of Big Data and Artificial Intelligence, has been designed to computationally discover and guide the development of life-science products based on microbes, small molecules and genetic elements. Utilizing the CPB platform, Evogene and its subsidiaries are now advancing product pipelines for human microbiome-based therapeutics through Biomica Ltd., medical cannabis through Canonic Ltd., ag-biologicals through Lavie Bio Ltd., ag-chemicals through AgPlenus Ltd., seed traits through the Ag-Seeds division, and ag-solutions for castor oil production through Casterra Ltd.
本社所在地 13 Gad Feinstein Street Park Rehovot P.O.B 2100 Rehovot 7612002 ISR
代表者氏名
代表者役職名
電話番号
設立年月日 2000年
市場名 NASDAQ National Market System
ipoyear ―年
従業員数 165人
url www.evogene.com
nasdaq_url https://www.nasdaq.com/symbol/evgn
adr_tso
EBITDA EBITDA ー
終値(lastsale) 2.95
時価総額(marketcap) 75975176.15
時価総額 時価総額 ―
売上高 売上高 --
企業価値(EV) 企業価値(EV) ー
当期純利益 当期純利益 --
決算概要 決算概要 --

 EVGNのテクニカル分析


 EVGNのニュース

   AgPlenus Announces Positive Results for a Herbicide Resistance Trait to its Leading Herbicide Product Candidate  2021/07/06 11:30:00 PR Newswire
REHOVOT, Israel, July 6, 2021 /PRNewswire/ -- AgPlenus Ltd., a company designing effective, sustainable crop protection products by leveraging computational biology and chemistry, and a subsidiary of Evogene Ltd. (NASDAQ: EVGN) (TASE: EVGN), announced today that it has achieved positive
   Agricultural Biotechnology Report 2021: Global Methodology, Research Findings, Size And Forecast To 2025| Evogene Ltd., Monsanto Company, Performance Plants Inc., KWS SAAT SE  2021/07/01 18:37:40 OpenPR
The report on the Global Agricultural Biotechnology Market includes basic research along with a comprehensive study of subjective and quantitative perspectives by various industry experts, leading home pioneers to gain an in-depth understanding of the market and industry practices. Based
   Evogene Announces Ms. Sarit Firon to become Evogene''s Chairperson of the Board  2021/06/23 11:00:00 PR Newswire
REHOVOT, Israel, June 23, 2021 /PRNewswire/ --Evogene Ltd. (NASDAQ: EVGN) (TASE: EVGN), a leading computational biology company aiming to revolutionize life-science product development across several market segments, announced today that its Board of Directors has resolved to appoint Ms.
   Evogene: Bullish With Canonic''s Entry Into Israeli Medical Cannabis Markets  2021/06/16 07:26:22 Seeking Alpha
   Evogene Ltd. (EVGN) CEO Ofer Haviv on Q1 2021 Results - Earnings Call Transcript  2021/05/26 18:32:07 Seeking Alpha
   Evogene: Bullish With Canonic''s Entry Into Israeli Medical Cannabis Markets  2021/06/16 07:26:22 Seeking Alpha
   Evogene Ltd. (EVGN) CEO Ofer Haviv on Q1 2021 Results - Earnings Call Transcript  2021/05/26 18:32:07 Seeking Alpha
   Shares of Medical Cannabis-Related Evogene Slightly Up On First Quarter Earnings  2021/05/26 16:30:36 Benzinga
Computational biology company Evogene Ltd. (NASDAQ: EVGN ) reported Wednesday its first-quarter financial results with revenue of $333,000, compared to $75,000 in the same period of 2020. Q1 Financial Highlights The companys gross profit for the period amounted to $62,000, which compares to $36,000 in the corresponding quarter of the prior year; The total operating expenses were of $6.32 million, compared to $6.89 million in the same period of 2020; The net loss for the quarter reached $7.1 million, which compares to a loss of $7.2 million in the first quarter of the previous year; Its operating loss for the period was $6.3 million, versus $6.9 million in the same period of 2020; A slightly lowered operating loss could Full story available on Benzinga.com
   Evogene shares rise on Q1 topline beat, cash update  2021/05/26 13:57:28 Seeking Alpha
   Evogene EPS beats by $0.01, beats on revenue  2021/05/26 11:38:40 Seeking Alpha
   Evogene Ltd. (EVGN) CEO Ofer Haviv on Q1 2021 Results - Earnings Call Transcript  2021/05/26 18:32:07 Seeking Alpha

 関連キーワード  (― 米国株 エボジェン EVGN Evogene Ltd.)

 twitter  (公式ツイッターやCEOツイッターなど)